Biosig Cash vs Net Debt Analysis
| BSGM Stock | USD 1.87 0.15 7.43% |
Biosig Technologies financial indicator trend analysis is way more than just evaluating Biosig Technologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biosig Technologies is a good investment. Please check the relationship between Biosig Technologies Cash and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.
Cash vs Net Debt
Cash vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biosig Technologies Cash account and Net Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Biosig Technologies' Cash and Net Debt is -1.0. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Net Debt in the same time period over historical financial statements of Biosig Technologies, assuming nothing else is changed. The correlation between historical values of Biosig Technologies' Cash and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Biosig Technologies are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Cash i.e., Biosig Technologies' Cash and Net Debt go up and down completely randomly.
Correlation Coefficient | -1.0 |
| Relationship Direction | Negative |
| Relationship Strength | Strong |
Cash
Cash refers to the most liquid asset of Biosig Technologies, which is listed under current asset account on Biosig Technologies balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Biosig Technologies customers. The amounts must be unrestricted with restricted cash listed in a different Biosig Technologies account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most indicators from Biosig Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biosig Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.At this time, Biosig Technologies' Issuance Of Capital Stock is very stable compared to the past year. As of the 8th of June 2024, Sales General And Administrative To Revenue is likely to grow to 1,346, while Enterprise Value Over EBITDA is likely to drop (1.31).
| 2023 | 2024 (projected) | Extraordinary Items | 2.9M | 2.6M | Reconciled Depreciation | 361K | 232.6K |
Biosig Technologies fundamental ratios Correlations
Click cells to compare fundamentals
Biosig Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biosig Technologies fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 14.2M | 30.4M | 15.5M | 4.1M | 1.8M | 1.7M | |
| Other Current Liab | 1.6M | 4.8M | 2.3M | 2.9M | 4.2M | 3.0M | |
| Total Current Liabilities | 2.0M | 5.1M | 2.6M | 3.3M | 4.6M | 3.2M | |
| Total Stockholder Equity | 11.4M | 24.5M | 12.3M | 418K | (2.9M) | (2.8M) | |
| Property Plant And Equipment Net | 894.7K | 595.0K | 1.3M | 1.5M | 938K | 531.7K | |
| Net Debt | (11.4M) | (28.0M) | (11.0M) | 408K | 262K | 275.1K | |
| Retained Earnings | (104.8M) | (157.0M) | (188.9M) | (216.0M) | (245.0M) | (232.8M) | |
| Cash | 12.1M | 28.3M | 11.7M | 357K | 190K | 180.5K | |
| Non Current Assets Total | 1.4M | 1.0M | 1.6M | 3.0M | 1.3M | 890.5K | |
| Non Currrent Assets Other | 129.2K | 107K | 42K | 1.2M | 43K | 40.9K | |
| Cash And Short Term Investments | 12.1M | 28.3M | 11.7M | 458K | 293K | 278.4K | |
| Common Stock Total Equity | 29.3K | 16.9K | 23.3K | 31K | 35.7K | 21.9K | |
| Common Stock Shares Outstanding | 2.1M | 2.8M | 3.4M | 4.3M | 7.4M | 7.7M | |
| Liabilities And Stockholders Equity | 14.2M | 30.4M | 15.5M | 4.1M | 1.8M | 1.7M | |
| Other Stockholder Equity | 115.9M | 181.3M | 201.1M | 216.2M | 242.1M | 254.2M | |
| Total Liab | 2.3M | 5.1M | 3.0M | 3.7M | 4.7M | 3.4M | |
| Property Plant And Equipment Gross | 894.7K | 595.0K | 1.8M | 2.4M | 2.5M | 2.6M | |
| Total Current Assets | 12.8M | 29.3M | 13.9M | 1.1M | 528K | 501.6K | |
| Common Stock | 23.3K | 31K | 36K | 55K | 9K | 8.6K | |
| Net Tangible Assets | 3.1M | 10.8M | 24.0M | 11.9M | 13.7M | 14.4M | |
| Warrants | 985K | 475K | 215K | 105K | 94.5K | 89.8K | |
| Accounts Payable | 346.2K | 30K | 1K | 2.9K | 2.6K | 2.4K | |
| Other Assets | 54.2K | 129K | (44.0) | 42K | 48.3K | 44.3K | |
| Retained Earnings Total Equity | (56.5M) | (70.7M) | (104.8M) | (157.0M) | (141.3M) | (134.2M) | |
| Capital Surpluse | 53.2M | 74.0M | 115.9M | 181.3M | 208.5M | 219.0M | |
| Other Current Assets | 141.2K | 301K | 354K | 325.0 | 314K | 181.2K | |
| Property Plant Equipment | 44.3K | 894K | 595K | 1.3M | 1.4M | 1.5M | |
| Non Current Liabilities Total | 311.1K | 1K | 378K | 452K | 103K | 175.3K | |
| Net Invested Capital | 11.1M | 24.4M | 12.2M | 313K | (3.0M) | (2.9M) | |
| Net Working Capital | 10.8M | 24.2M | 11.3M | (2.1M) | (4.1M) | (3.9M) | |
| Capital Stock | 238.3K | 136K | 141K | 160K | 114K | 170.8K | |
| Intangible Assets | 365.7K | 347K | 327K | 308K | 289K | 254.2K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Biosig Technologies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Biosig Stock
When determining whether Biosig Technologies is a strong investment it is important to analyze Biosig Technologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biosig Technologies' future performance. For an informed investment choice regarding Biosig Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biosig Technologies. If investors know Biosig will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biosig Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.12) | Revenue Per Share 0.003 | Quarterly Revenue Growth 1.8 | Return On Assets (4.48) | Return On Equity (59.77) |
The market value of Biosig Technologies is measured differently than its book value, which is the value of Biosig that is recorded on the company's balance sheet. Investors also form their own opinion of Biosig Technologies' value that differs from its market value or its book value, called intrinsic value, which is Biosig Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biosig Technologies' market value can be influenced by many factors that don't directly affect Biosig Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biosig Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biosig Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biosig Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.